At recent prices, you can buy shares of Merck (NYSE: MRK) that offer a yield above 3%, and shares of Pfizer (NYSE: PFE) offer ...

Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...

Merck said the Phase 3 "Hyperion" study, which was evaluating Winrevair versus placebo in recently diagnosed adults with PAH at intermediate or high risk of disease progression, had lost clinical ...

Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...

During health secretary nominee Robert F. Kennedy Jr.'s Jan. 29 Senate confirmation hearing, Sen. Elizabeth Warren, D-Mass., ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in previous studies, the drugmaker said on Thursday.

The rise of misinformation online has helped fringe health ideas go mainstream and eased RFK Jr.'s path to confirmation as ...

Robert F. Kennedy Jr. has cleared his first hurdle to become the nation’s top health official as the Senate finance committee ...

Merck said the allegations have no merit ... The firm recently sued some of the nation’s largest food manufacturers, accusing them of using a “cigarette playbook to fill our food environment ...

Merck CEO Rob Davis told CNBC's Jim Cramer that ... a rare and life-threatening lung condition that was approved by the Food and Drug Administration last spring. Winrevair is the first drug ...

Hormel Foods, United Parcel Service, Elevance Health, Johnson & Johnson, PepsiCo, Pfizer, Merck, Intuit, Qualcomm, and MSA Safety. Analyst’s Disclosure: I/we have a beneficial long position in ...